We are live on ! Find out more

Waters Corp

WAT

Market cap $44.4B

451.94 USD

-3.65

0.8%

At close Updated Oct 23, 2:47 PM EDT

1 day

-0.8%

5 days

3.53%

1 month

7.46%

3 months

18.18%

6 months

45.22%

Year to date

18.32%

1 year

27.06%

5 years

23.29%

10 years

186.49%

About: Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with Becton Dickinson's life science and diagnostics business, which increased its concentration in diagnostics and discovery-related life science tools.

Employees: 7,900

Healthcare Diagnostics & Research

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 41.9%

Neutral 54.8%

Negative 3.2%

Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026

Labcorp intends to be the first commercial laboratory to offer FDA-approved HPV testing with the BD Onclarity™ HPV Assay across clinician-collected and self-collected screening options in clinic, patient service center, and at-home settings Through a network serving more than 850,000 physicians and healthcare providers and more than 2,200 patient service centers, Labcorp is helping expand access to cervical cancer screening nationwide First and only FDA-approved HPV test that supports all ASCCP Enduring Risk-Based Management Guidelines by providing comprehensive extended genotyping MILFORD, Mass. and BURLINGTON, N.C.

Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026

Zacks Investment Research

Waters Launches AI Link to Advance AI-Enabled LC-MS Workflows

WAT's AI Link launch and Anthropic collaboration aim to automate LC-MS workflows, streamline lab operations and drive instrument demand.

Waters Launches AI Link to Advance AI-Enabled LC-MS Workflows

Waters Corporation and Quest Diagnostics Help Close Cervical Cancer Screening Gap Bringing Nationwide Access to the Most Comprehensive FDA-Cleared At-Home HPV Screening Option

Expands access to most comprehensive FDA-approved HPV test and at-home self-collection option across Quest's national clinician, health plan, and consumer channels starting in 2027 First and only FDA-approved HPV test that supports all ASCCP Enduring Risk-Based Management Guidelines by providing comprehensive extended genotyping Quest Diagnostics serves half of U.S. physicians and hospitals and one in three American adults each year MILFORD, Mass. and SECAUCUS, N.J.

Waters Corporation and Quest Diagnostics Help Close Cervical Cancer Screening Gap Bringing Nationwide Access to the Most Comprehensive FDA-Cleared At-Home HPV Screening Option

Two stocks poised to benefit from rotation out of AI

Investors looking beyond artificial intelligence (AI) should closely watch two healthcare names – Thermo Fisher Scientific (TMO) and Waters (WAT) – according to Josh Brown. In his latest report, the Ritholtz' chief executive highlighted laboratory equipment suppliers whose improving businesses are attracting buyers as tech stocks face pressure.

Two stocks poised to benefit from rotation out of AI

Waters Launches AI Link, Advancing AI-Enabled LC-MS Workflows from Research to Release

Accelerates research and development by enabling AI-augmented workflows and automated lab-in-the-loop cycles, already a new and fast-growing source of demand for Waters' instruments and consumables Leverages Waters' unique ability to take an AI-directed experiment from the research bench into development and into Empower™ Software, carrying its audit trail as the molecule moves into downstream, regulated settings Joins Anthropic's Model Hardware Standard (MHS) research program designed to enable AI agents to operate Waters instrument hardware directly and autonomously, cutting instrument integration from weeks to hours Brings Anthropic's Model Context Protocol (MCP) to waters_connect™ Software, enabling scientists to direct Waters instruments through proprietary agents linked to large language models (LLMs), as well as Claude Science MILFORD, Mass., Oct. 13, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today announced that it has launched Waters AI Link, a software capability that brings Anthropic's Model Context Protocol (MCP) to its informatics platform and has joined Anthropic's Model Hardware Standard (MHS) research program.

Waters Launches AI Link, Advancing AI-Enabled LC-MS Workflows from Research to Release

Zacks Investment Research

Here's Why You Should Retain WAT Stock in Your Portfolio for Now

Waters' growth outlook is fueled by strong analytical sciences demand, BD synergies and innovation, even as China weakness and integration risks persist.

Here's Why You Should Retain WAT Stock in Your Portfolio for Now

Waters Corporation Schedules Third Quarter 2026 Earnings Conference Call

MILFORD, Mass., Oct. 1, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) will hold its Q3 2026 financial results conference call on Tuesday, November 3, 2026, at 8:00 a.m.

Waters Corporation Schedules Third Quarter 2026 Earnings Conference Call

Waters Tops Growth Outlook as AI Demand, BD Integration Fuel Momentum

Waters NYSE: WAT President and Chief Executive Officer Udit Batra said the company's second-quarter performance exceeded expectations, supported by broad-based growth in its legacy analytical-science operations and early progress integrating acquired Becton Dickinson businesses.

Waters Tops Growth Outlook as AI Demand, BD Integration Fuel Momentum

Waters: Positive Momentum Rides High Again

Waters has rebounded sharply, with shares rising from $300 to $425 on solid organic and acquired sales growth. Water's full-year earnings guidance has only been modestly raised to $14 and change per share, despite significant share price appreciation. Valuation has expanded to 28–29x earnings, making the stock less appealing despite credible margin expansion and growth plans.

Waters: Positive Momentum Rides High Again

Waters Corporation (WAT) Presents at U.S. All Stars Conference Transcript

Waters Corporation (WAT) Presents at U.S. All Stars Conference Transcript

Waters Corporation (WAT) Presents at U.S. All Stars Conference Transcript

See News Rankings

Price charts implemented using Lightweight Charts™